Kaposi's Sarcoma Herpes Virus Taps into a Host MicroRNA Regulatory Network  by McClure, Lydia V. & Sullivan, Christopher S.
Cell Host & Microbe
PreviewsKaposi’s Sarcoma Herpes Virus Taps
into a Host MicroRNA Regulatory Network
Lydia V. McClure1 and Christopher S. Sullivan1,*
1Molecular Genetics and Microbiology, The University of Texas at Austin, 1 University Station A5000, Austin, TX 78712-0162, USA
*Correspondence: chris_sullivan@mail.utexas.edu
DOI 10.1016/j.chom.2007.12.002
Kaposi’s sarcoma-associated herpes virus (KSHV), the causative agent of several neoplasms, has recently
been shown to encode 12 microRNAs. mir-155 is a host-encoded microRNA associated with lymphomagen-
esis. Two newpapers provide strong evidence that a KSHV-encodedmicroRNA andmir-155 share a common
set of mRNA targets and binding sites, implying a possible link between viral- and non-viral-mediated tumor-
igenesis.The most recently discovered human her-
pesvirus, Kaposi’s sarcoma-associated
herpes virus (KSHV), is a large DNA virus
that encodes over 80 different proteins.
KSHV is the causative agent of several dis-
eases including Kaposi’s sarcoma (KS,
a highly vascularized skin lesion) and the
hyperproliferative B cell disorders primary
effusion lymphoma (PEL) and multicentric
Castleman’s disease. Numerous studies
of individual proteins have explored
KSHV-mediated tumorigenesis; however,
a comprehensive understanding of the
mechanism remains obscure. The recent
discovery that KSHV encodes 12 micro-
RNAs (miRNAs) raises the possibility that
these non-protein-coding gene products
may contribute to viral-induced tumori-
genesis (Cai et al., 2005; Grundhoff et al.,
2006; Pfeffer et al., 2005; Samols et al.,
2005).
miRNAs are small,22 nt RNAs that are
processed from longer hairpin precursor
transcripts into an effector complex able
to bind to and prevent protein expression
from specific mRNAs (Figure 1). Through
both computational sequence matching
and experimental observations, it is clear
that the 50 end of the miRNA, the so-called
seed region (nucleotides 2–8), plays a
critical role in mRNA target recognition.
Binding of a miRNA to a mRNA typically
results in reduced translation. Some tar-
geted transcripts also have lower steady
state levels, thereby allowing for experi-
mental determination of some miRNA
targets via cDNA microarray expression
analysis. Each miRNA may bind to numer-
ous (estimated to be over 100) mRNA
targets involved in a particular biological
process. For example, miRNAs that are
involved in regulation of muscle and neu-ronal cell development have been eluci-
dated, and experimental determination
of their mRNA targets identified numerous
mRNAs with seed complements in their
30UTR (Lim et al., 2005). These data imply
the existence of regulatory networks in
which miRNAs act as nodal effectors
that target specific sequences found in
the 30UTRs of a set of transcripts. Pre-
sumably, each set is involved in a particu-
lar biological process that requires similar
temporal or spatial regulation of member
transcripts.
At last count, over 120 viral-encoded
miRNAs have been reported, mostlyCell Host & Micfrom members of the herpesvirus and
polyomavirus families. The functions of the
majority are unknown; however, molecu-
lar targets have been identified for a few.
Some viral miRNAs target viral transcripts
by directing their cleavage or translational
repression. In addition, some viral miRNAs
direct translational repression of host
transcripts by binding to viral-specific
sites. However, until now, no viral miRNAs
have been reported that bind to mRNA tar-
gets via sites utilized by host miRNAs. Two
recent reports now show that at least one
viral miRNA, KSHV mir-K12-11, has the
potential to regulate multiple transcriptsFigure 1. Human mir-155 and KSHV mir-k12-11 Regulate a Shared Set of mRNA Targets
The precursor hairpin RNA (pre-miRNA) that gives rise to mir-155 is contained within the noncoding RNA
BIC (B cell integration complex). mir-k12-11 is generated from a primary transcript (pri-miRNA) that gives
rise to multiple KSHV miRNAs. Drosha cleavage in the nucleus of both pri-miRNA transcripts releases
a short-hairpin structured pre-miRNA, which is exported to the cytoplasm. Subsequently, Dicer cleavage
of the pre-miRNA into the 22 nucleotide miRNA occurs. This is followed by assembly of the miRNA into
the multi-protein RNA-induced silencing complex (RISC), which allows for targeted downregulation of
specific host mRNA transcripts. When exogenously expressed, mir-155 and KSHV mir-k12-11 share sev-
eral common mRNA targets and binding sites, such as the transcriptional regulators BACH-1 and FOS, as
well as the proapoptotic effector LDOC-1.robe 3, January 2008 ª2008 Elsevier Inc. 1
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host miRNA, mir-155 (Gottwein et al.,
2007; Skalsky et al., 2007).
Mir-155 is a miRNA with a particularly
interesting history. It is contained within
the noncoding RNA product of the B cell
integration complex (BIC) gene, which
had been a suspected proto-oncogene
before the discovery of miRNAs. BIC was
originally identified as a common integra-
tion site of avian leukosis virus (ALV)-
induced lymphomas and has been shown
in co-overexpression studies to cooperate
with c-myc to enhance lymphomagenesis
(Tam et al., 1997). Mir-155 is upregulated
in some human lymphomas and plays
a role in the adaptive immune response,
likely by controlling cytokine production
(Thai et al., 2007). KSHV is the causative
agent of PEL and KS, both of which are as-
sociated with aberrant cytokine produc-
tion. Thus, the realization of a conserved
seed sequence raises the exciting possi-
bility that mir-k12-11 may be contributing
to tumorigenesis by tapping into the
same network of transcripts that mir-155
regulates.
The observation that mir-k12-11 shares
sequence identity in the seed region with
mir-155 was first noted in a review article
by Nair and Zavolan (2006). These authors
suggested this shared seed identity could
be an example of convergent evolution,
thus implying a common set of targets
and a shared function. However, it was al-
ternatively possible that this shared seed
sequence identity was inconsequential,
and the differences in the remaining, non-
seed nucleotides would confer differential
target specificity. Now, both Skalsky et al.
and Gottwein et al. clearly show that when
exogenously expressed, mir-k12-11 and
mir-155 downregulate the expression of
a common set of shared cellular mRNA
targets.
Both groups expressed mir-k12-11 and
performed cDNA microarray gene expres-
sion analysis to identify candidate mRNA
targets whose steady state levels are re-
duced in the presence of mir-k12-11. Skal-
sky et al. (2007) analyzed stable pools of
human embryonic kidney cells (HEK293)
that were transfected with a plasmid driv-
ing expression via the cytomegalovirus
(CMV) promoter. Utilizing a different cell
type and expression system, Gottwein
et al. (2007) profiled a B cell lymphoma
line transduced with a lentiviral vector ex-
pressing a chimeric pre-miRNA hairpin2 Cell Host & Microbe 3, January 2008 ª200Figure 2. Common mRNA Targets of Both Human mir-155 and mir-k12-11 Are Involved in
Cellular Processes with Potential Relevance to Tumorigenesis
Identical seed sequence (nucleotides 2–8) allows both mir-155 and mir-k12-11 to regulate a common set
of mRNA targets. Skalsky et al. (2007) and Gottwein et al. (2007) used a combination of computational
prediction and microarray cDNA expression analysis to identify candidate targets.designedtogenerateexpressionof the fully
processed mir-k12-11. Both reports com-
bined prediction algorithms with microar-
ray analysis to generate a list of candidate
mRNA targets regulated by mir-k12-11.
Next, Skalsky et al. (2007) additionally
applied microarray analysis to cells exog-
enously expressing mir-155, while Gott-
wein et al. (2007) selected several mir-
k12-11 candidate targets and subjected
them to real-time PCR expression analysis
in cells exogenously expressing mir-155.
Each group independently concluded
that both mir-k12-11 and mir-155 have
the ability to regulate a common set of
mRNA targets. It is notable, though, that
there is little overlap among the targets
identified in each study. Importantly, how-
ever, the targets from both studies are en-
riched for complements to the mir-k12-11
and mir-155 seed region and selected
targets were shown by each group to be
direct targets in heterologous luciferase
reporter assays.
Interestingly, both groups identified
BACH-1, a transcriptional repressor in-
volved in hypoxia signaling, as a target for
exogenously expressed mir-k12-11 and
mir-155. Computational methods were
used to identify BACH-1 as a candidate
target, yet neither group detected robust
changes in BACH-1 mRNA steady state
levels upon expression of mir-k12-11 or
mir-155. However, heterologous luciferase
reporters containing portions of the BACH-
1 30 UTR were specifically downregulated
by exogenous expression of either mir-
k12-11 or mir-155, implying a majority of
the regulation occurs at the level of transla-
tion. Furthermore, immunoblot analysis8 Elsevier Inc.showed BACH-1 steady state protein
levels decreased several fold by exoge-
nous expression of either mir-k12-11 or
mir-155 in monocyte or B lymphocyte cells
(Gottwein et al., 2007; Skalsky et al., 2007).
These results strongly implicate BACH-1
as a target for downregulation by exoge-
nous expression of either mir-k12-11 or
mir-155.
Although these experimental appro-
aches are standard for the field, one po-
tential caveat is that exogenous expres-
sion may somehow bias which candidate
mRNA targets are identified. Therefore,
a higher level of confidence can be ob-
tained when antisense inhibitors of endog-
enous miRNAs are used in conjunction
with exogenous expression studies. Gott-
wein et al. (2007) showed that at least one
candidate, FOS (part of the AP-1 transcrip-
tional activator complex) is targeted by
endogenous mir-k12-11; PEL cells that
uptake a cholesterol-modified antisense
inhibitor of mir-k12-11 show an increase
in endogenous FOS protein levels. Sur-
prisingly, BACH-1 showed little increase
in expression under the same experimen-
tal conditions. The authors suggest this is
likely due to ‘‘masking’’ of the mir-k12-11
inhibitory effects, since BACH-1 is also
targeted by two other KSHV-encoded
miRNAs (mir-k12-1 and mir-k12-6). This
is one of the only points of contention
between the two reports, since Skalsky
et al. (2007) also tested mir-k12-6, yet ob-
served no effect on BACH-1 30 UTR re-
porters. One possible explanation for this
apparent discrepancy is that mir-k12-1,
which was not tested by Skalsky et al.
(2007), has a more dramatic effect on
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strategies directed against both endoge-
nous mir-k12-11 and mir-155 could help
identify which candidate targets are sub-
jects for more in depth study.
To better understand KSHV-associated
pathogenesis, it will be important to test
the most promising candidate miRNA tar-
gets in other relevant models, such as cul-
tured primary endothelial cells as well as
in vivo models. KSHV is particularly adept
at ‘‘pirating’’ host protein coding genes
into its genome; thus, it makes sense
that KSHV would also tap into an existing
host miRNA regulatory pathway. From
a viral perspective, the ability to target
many genes involved in an existing regu-
latory network may provide more ‘‘evolu-
tionary bang for your buck.’’ Indeed, it is
likely that this strategy is not unique to
KSHV, as other viral miRNAs display vari-
ous degrees of seed identity with host
miRNAs (Gottwein et al., 2007; Skalsky
et al., 2007).Defensins’ Offens
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Vertebrates rely on antimicrobial
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binding of the defensin to the virus
Vertebrates employ an impressive arsenal
of molecular weapons to defend them-
selves against invading microbes. One
defense mechanism involves the local
release of noxious chemicals, such as
reactive oxygen intermediates, that are
capable of directly destroying microbial
structures. Obviously, the use of such
broadly reactive chemicals must be tightly
controlled to avoid catastrophic damage
to host tissues. Control over these sys-
tems typically involves a variety of signal-On the whole, these two studies sug-
gest that mir-k12-11 and mir-155 share
a set of common mRNA targets that
form a part of a regulatory network impor-
tant for B cell function, cell-cycle regula-
tion, and apoptosis. All of these pathways
could play an important role in the lym-
phomagenesis associated with misex-
pression of mir-155 or KSHV infection
(Figure 2). This is an exciting time in the
world of viral miRNAs, where the field is
poised for an avalanche of miRNA tar-
get discoveries. The next challenge will
be to integrate these findings into a better
understanding of viral life cycle and
pathogenesis.
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